Revenio Group OyjREVXF 82 PEG Ratio is 4.98 as of Jul. 05, 2026, which is 81% above its 10-year median of 2.75. GuruFocus rates REVXF with a GF Score™ of 82/100 and a GF Value™ of $40.45 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 208 Medical Devices & Instruments companies, Revenio Group Oyj ranks worse than 79.81% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Revenio Group Oyj's PEG Ratio or its related term are showing as below:
REVXF'
s PEG Ratio Range Over the Past 10 Years
Min: 1 Med: 2.75 Max: 10.13
Current: 4.44
During the past 13 years, Revenio Group Oyj's highest PEG Ratio was 10.13. The lowest was 1.00. And the median was 2.75.
REVXF's PEG Ratio is ranked worse than 79.81% of 208
companies
in the Medical Devices & Instruments industry
Industry Median: 1.99
vs REVXF: 4.44
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Revenio Group Oyj (OTCPK:REVXF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Revenio Group Oyj PEG Ratio Related Terms
Revenio Group Oyj PEG Ratio Historical Data
* Premium members only.
The historical data trend for Revenio Group Oyj's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Revenio Group Oyj's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revenio Group Oyj PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Revenio Group Oyj's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Revenio Group Oyj (REVXF) has a PEG Ratio of 4.98 as of Jul. 05, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Revenio Group Oyj and its competitors. This is 81% above median its historical median of 2.75. Over the past decade, Revenio Group Oyj's PEG Ratio has ranged from 1.00 to 10.13. According to the industry distribution chart, Revenio Group Oyj ranks #166 out of 208 companies in the Medical Devices & Instruments industry, placing it in the top 79.8%.
Is Revenio Group Oyj's PEG Ratio too high?
Revenio Group Oyj's current PEG Ratio of 4.98 is 81% above median its 10-year median of 2.75. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.13. The Medical Devices & Instruments industry median PEG Ratio is 1.99. Revenio Group Oyj's value of 4.98 is 150.3% above this industry median. Based on the distribution chart, Revenio Group Oyj ranks #166 out of 208 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Revenio Group Oyj has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's PEG Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Revenio Group Oyj ranks #166 out of 208 companies for PEG Ratio. This places Revenio Group Oyj in the lower half of its industry. The industry median PEG Ratio is 1.99. Revenio Group Oyj's value of 4.98 is 150.3% above this benchmark. Historically, Revenio Group Oyj's own PEG Ratio has ranged from 1.00 to 10.13 over the past decade. While the company's 10-year median is 2.75 vs. the industry median of 1.99, Revenio Group Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.99, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Revenio Group Oyj's current PEG Ratio of 4.98 is 150.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Revenio Group Oyj and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revenio Group Oyj's current PEG Ratio is 4.98, which is 81% above median its own 10-year median of 2.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Based on GuruFocus' analysis, Revenio Group Oyj (REVXF) is currently considered Significantly Undervalued. The stock's GF Value™ is $40.45, compared to a current price of $16.41 — trading 59.4% below its estimated fair value. The current PEG Ratio is 4.98, which is 81% above median its 10-year median of 2.75 and 150.3% above the Medical Devices & Instruments industry median of 1.99. Revenio Group Oyj's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Revenio Group Oyj (REVXF), the current PEG Ratio is 4.98 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Revenio Group Oyj (REVXF) Overvalued in 2026?
Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued.
The current stock price of $16.41 is trading 59.4% below its estimated GF Value™ of $40.45.
GuruFocus considers Revenio Group Oyj to be Significantly Undervalued.
Key valuation signals for REVXF:
PEG Ratio: 4.98 (81% above median its 10-year median of 2.75)
GF Value™: $40.45 vs. price of $16.41 (59.4% below fair value)
Industry Position: 150.3% above the Medical Devices & Instruments median (#166 of 208)
No single metric tells the full story. See the REVXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
82GF Score
Get the complete analysis for REVXF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
REVXF has been successfully added to your 
